Robots in Healthcare
August 1, 2022Article of the Month – August 2022
August 1, 2022Brazil
RadVid-19 seeks to fill the gap of under-testing COVID-19 in Brazil. Brazilian startup makes non-invasive sensors to determine intracranial pressure...
GlucoGear
GlucoGear is a company founded in 2015 in Sao Paulo, Brazil. GlucoGear offers a mobile app for diabetes management. The app integrates multivariable data analysis for patients to monitor blood glucose levels, diet, activity, and medicines. The most distinctive feature of GlucoGear is its predicting capability of blood glucose, which would help patients avoid hyperglycemic or hypoglycemic episodes.
The app can also recommend changing actions such as meal switching, injecting additional insulin, and data-driven eating reminders to keep glucose levels under control. In this way, the app not only allows the patient to control blood glucose levels better but also enhances diabetes self-management, improves healthcare literacy, and promotes patient engagement, all associated with better treatment compliance. Diabetes can lead to multiple complications if it is not well managed; GlucoGear is an excellent way to control blood glucose and prevent disease progression.(1)
GlucoGear is a company founded in 2015 in Sao Paulo, Brazil. GlucoGear offers a mobile app for diabetes management. The app integrates multivariable data analysis for patients to monitor blood glucose levels, diet, activity, and medicines.
The most distinctive feature of GlucoGear is its predicting capability of blood glucose, which would help patients avoid hyperglycemic or hypoglycemic episodes. The app can also recommend changing actions such as meal switching, injecting additional insulin, and data-driven eating reminders to keep glucose levels under control. In this way, the app not only allows the patient to control blood glucose levels better but also enhances diabetes self-management, improves healthcare literacy, and promotes patient engagement, all associated with better treatment compliance. Diabetes can lead to multiple complications if it is not well managed; GlucoGear is an excellent way to control blood glucose and prevent disease progression.(1)
Brain4care
Brain4care is a company founded in 2019 in Sao Carlos, Brazil. The company offers a non-invasive medical sensor that provides access to intracranial pressure waveform without surgery. The importance of monitoring the intracranial pressure (ICP) is that it can aid in diagnosing an underlying etiology causing elevations in the ICP. In addition, the sensor is safe and does not emit radiation, ultrasound waves, or other biological risks.(2)
Brain4care is a company founded in 2019 in Sao Carlos, Brazil. The company offers a non-invasive medical sensor that provides access to intracranial pressure waveform without surgery.
The importance of monitoring the intracranial pressure (ICP) is that it can aid in diagnosing an underlying etiology causing elevations in the ICP. In addition, the sensor is safe and does not emit radiation, ultrasound waves, or other biological risks.(2)
Kidopi
Kidopi is a healthcare technology company founded in 2009 in Ribeirao Preto, Brazil. The company works on hospital management, computerization of clinics and offices, emergency medical coordination, medical imaging systems, and support for academic research. Kidopi is also multilevel-care friendly, working from primary care to tertiary level of health.
One of the most outstanding products of the company is its CleverCare platform, which gives the patient personalized, predictive, preventive, and participatory care by establishing continuous channels for automatic communication; this gives providers better control of the clinical course of patients.(3)
Kidopi is a healthcare technology company founded in 2009 in Ribeirao Preto, Brazil. The company works on hospital management, computerization of clinics and offices, emergency medical coordination, medical imaging systems, and support for academic research.
Kidopi is also multilevel-care friendly, working from primary care to tertiary level of health. One of the most outstanding products of the company is its CleverCare platform, which gives the patient personalized, predictive, preventive, and participatory care by establishing continuous channels for automatic communication; this gives providers better control of the clinical course of patients.(3)
TNH health
TNH health is a company founded in 2013 in Rio Negrinho, Brazil. The company’s main focus is on primary care. It provides AI-based chatbots that monitor the population’s health by identifying individual risks and recommending actionable insights to prevent progression to significant illnesses.
These chatbots, additionally, allow chronic disease management (such as diabetes and hypertension), counseling to mothers throughout pregnancy, lifestyle changes (such as tobacco use cessation and weight management), postoperative monitoring, and epidemic control by public health organizations for epidemic control.(4)
TNH health is a company founded in 2013 in Rio Negrinho, Brazil. The company’s main focus is on primary care. It provides AI-based chatbots that monitor the population’s health by identifying individual risks and recommending actionable insights to prevent progression to significant illnesses.
These chatbots, additionally, allow chronic disease management (such as diabetes and hypertension), counseling to mothers throughout pregnancy, lifestyle changes (such as tobacco use cessation and weight management), postoperative monitoring, and epidemic control by public health organizations for epidemic control.(4)
Ophthalmology
The Brazilian startup Phelcom created a device named Eyer, a portable device connected to a smartphone that produces an accurate retinal photograph. Eyer can detect fundus disease at a much lower cost than traditional methods and sends the images to a cloud called Eyer Cloud. If the user does not have Wi-Fi or access to a 3G or 4G network, the images are stored in the smartphone and sent to the cloud when an internet connection becomes available.
Its portability and connectivity allow examinations to be performed at any location without eye drops for pupil dilation or expert providers in rural areas, reducing time, costs, and healthcare accessibility, giving patients more comfort and faster results. Eyer is a convenient solution for early detection and monitoring of diabetic retinopathy, glaucoma, AMD (age-related macular degeneration), retinal detachment, retinoblastoma, retinopathy of prematurity, and many other diseases. Many Brazilian ophthalmologists are using Eyer, and it promises to expand further throughout primary care.(6)
The Brazilian startup Phelcom created a device named Eyer, a portable device connected to a smartphone that produces an accurate retinal photograph. Eyer can detect fundus disease at a much lower cost than traditional methods and sends the images to a cloud called Eyer Cloud.
If the user does not have Wi-Fi or access to a 3G or 4G network, the images are stored in the smartphone and sent to the cloud when an internet connection becomes available. Its portability and connectivity allow examinations to be performed at any location without eye drops for pupil dilation or expert providers in rural areas, reducing time, costs, and healthcare accessibility, giving patients more comfort and faster results. Eyer is a convenient solution for early detection and monitoring of diabetic retinopathy, glaucoma, AMD (age-related macular degeneration), retinal detachment, retinoblastoma, retinopathy of prematurity, and many other diseases. Many Brazilian ophthalmologists are using Eyer, and it promises to expand further throughout primary care.(6)
Radiology
Specialists in Brazil are utilizing AI as another instrument in their battle against COVID-19 through the platform named RadVid-19, supported by The Brazilian College of Radiology and Diagnostic Imaging. This AI tool uses algorithms from the Chinese firm Huawei and the German company Siemens. The platform is a repository of COVID cases in Brazil, collecting confirmed or suspected X-rays and tomography exams of COVID-19 patients.
Then, these exams get organized and classified according to the severity of the cases. Doctors get access to the system and can quickly and effectively identify patients with COVID-19, allowing rapid action and medical intervention. RadVid-19 seeks to fill the gap of under-testing in the South American country.(7)
Specialists in Brazil are utilizing AI as another instrument in their battle against COVID-19 through the platform named RadVid-19, supported by The Brazilian College of Radiology and Diagnostic Imaging. This AI tool uses algorithms from the Chinese firm Huawei and the German company Siemens. The platform is a repository of COVID cases in Brazil, collecting confirmed or suspected X-rays and tomography exams of COVID-19 patients.
Then, these exams get organized and classified according to the severity of the cases. Doctors get access to the system and can quickly and effectively identify patients with COVID-19, allowing rapid action and medical intervention. RadVid-19 seeks to fill the gap of under-testing in the South American country.(7)